Brief: Curis Announces Encouraging Emavusertib Data At 2022 American Society Of Clinical Oncology Annual Meeting (ASCO)
04/06/2022 16:11
June 4 (Reuters) - Curis Inc CRIS.O :
* CURIS ANNOUNCES ENCOURAGING EMAVUSERTIB DATA AT 2022
AMERICAN
SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING (ASCO)
Source text for Eikon: ID:nPn57hY4ba
Further company coverage: CRIS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Curis
See all newsCuris Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Curis Announces Pricing Of $5.6 Million Public Offering
Curis Inc expected to post a loss of $7.84 a share - Earnings Preview
Curis Inc expected to post a loss of $7.47 a share - Earnings Preview
Brief: Curis Doses First Five Patients In Takeaim Cll Study